Medicalgorithmics, a leading global medtech company, is proud to announce its partnership with a prominent Independent Diagnostic Testing Facility (IDTF) located in the United States. This alliance underscores Medicalgorithmics' unwavering dedication to elevating the field of cardiology through its state-of-the-art technological solutions.

The agreement facilitates the integration of Medicalgorithmics' AI-driven software platform into the IDTF's cardiac arrhythmia patient monitoring systems, thus enhancing the IDTF's competitive edge and operational efficiency. As part of this collaboration, monitoring hardware from various manufacturers will be consolidated onto a singular software platform, equipped with multi-modality features, including Holter, Ext. Holder, Event Monitoring, and MCT. According to the contract, Medicalgorithmics will receive remuneration for each session analyzed and reported.

The partnership anticipates a seamless alignment of Medicalgorithmics' software with the IDTF's patient monitoring devices. This will streamline the processes of reviewing, analyzing, and reporting patient data for IDTF technicians. Importantly, the software provides the IDTF with sophisticated tools, facilitating the creation of high-quality reports for medical professionals and ensuring instant access to comprehensive, beat-by-beat annotated data. Such in-depth insights are crucial for determining optimal treatment routes.

"The signing of this contract emphasizes our commitment to harnessing the potential of AI and forming partnerships to redefine cardiac diagnostics. With this collaboration, we're set to expand the reach of our innovative technology, benefiting even more healthcare professionals and patients. Our ultimate aim remains enhancing patient outcomes and the overall quality of care." - stated James Landis, VP of Sales and Business Development for North America at Medicalgorithmics.

Medicalgorithmics is a global medtech company, specialized in AI-enhanced, non-invasive cardiac arrhythmia solutions. Its broad portfolio of products augments patient monitoring, enabling prompt ailment detection, accurate diagnosis, and meticulous health oversight. Such innovations provide healthcare professionals with unparalleled insights, optimize workflows, and substantially curtail the need for manual data assessments by technicians.

The publication can be downloaded here:

Download
  • August 7, 2023

Attachments

Disclaimer

Medicalgorithmics SA published this content on 07 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 August 2023 08:48:26 UTC.